Companies / AMGN vs MRNA
AMGN vs MRNA: Amgen and Moderna
Amgen (AMGN) reported $36.8B in revenue against a 21.0% net margin, while Moderna (MRNA) reported $1.9B at a -145.2% net margin, most recently.
| Metric | AMGN | MRNA |
|---|---|---|
| Revenue | $36.8B | $1.9B |
| Net Income | $7.7B | $-2.8B |
| Gross Margin | 67.2% | 55.3% |
| Operating Margin | 24.7% | -158.1% |
| EPS (Diluted) | $14.23 | $-7.26 |
| Free Cash Flow | $8.1B | $-2.1B |
| Total Debt | $54.6B | $0.6B |
| P/E Ratio | 23.0× | n/m |
| P/B Ratio | 20.4× | 1.3× |
| Stock Price | $463.61 | $241.26 |
Free: last 5 years
| Fiscal year | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| AMGN Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $26.0B | $26.3B | $28.2B | $33.4B | $36.8B |
| MRNA Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $18.5B | $19.3B | $6.8B | $3.2B | $1.9B |